Effects of N-Acetylprocainamide and Procainamide on Myocardial Contractile Force, Heart Rate, and Blood Pressure
- 1 July 1979
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 161 (3) , 332-336
- https://doi.org/10.3181/00379727-161-40547
Abstract
The effects of N-acetylprocainamide (NAPA) and procainamide (PA) on myocardial force of contraction were compared in open-chest, vagotomized, pentobarbital-anesthetized dogs, with the use of a Walton-Brodie strain gauge sutured to the right ventricle. NAPA increased myocardial force of contraction, particularly at the high dose level (40 mg/kg). PA, had a negative inotropic effect that was equally apparent at all doses (10-40 mg/kg). Both NAPA and PA had a negative chronotropic effect and caused a reduction in mean arterial pressure. The mechanisms of the inotropic and hypotensive actions of NAPA require elucidation. Possible clinical use of NAPA as an antiarrhythmic agent are discussed.This publication has 6 references indexed in Scilit:
- Long‐term antiarrhythmic therapy with N‐acetylprocainamideClinical Pharmacology & Therapeutics, 1979
- Serum Levels and Electrophysiological Effects of N‐Acetylprocainamide as Compared with Procainamide in the Dog Heart in situActa Pharmacologica et Toxicologica, 1978
- Dose‐ranging trial of N‐acetylprocainamide in patients with premature ventricular contractionsClinical Pharmacology & Therapeutics, 1977
- The Antiarrhythmic Properties of Lidocaine and Procaine AmideCirculation, 1963
- Resistance Strain Gauge Arches for Direct Measurement of Heart Contractile Force in Animals.Experimental Biology and Medicine, 1953
- Circulatory Changes Affecting Measurement of Heart Force in Situ With Strain Gauge ArchesAmerican Journal of Physiology-Legacy Content, 1953